FDA NDC Directory · JSON-LD · Markdown

Dabigatran Etexilate

NDC 72603-239 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerNorthStar RxLLC
Marketing categoryAbbreviated NDA (generic) · App ANDA207961
Dosage form / routeCAPSULE · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (150 mg/1)
Marketing started20251201
Package count1

External sources

Source: openFDA. Public-domain (CC0).